Remdesivir

‌Remdesivir (CAS 1809249-37-3)‌
🌟 ‌ChemicalBook Product Introduction‌

📌 ‌Product Overview‌

‌Remdesivir‌ (GS-5734) is a ‌broad-spectrum antiviral nucleotide analog‌ with the molecular formula ‌C27H35N6O8P‌. As a prodrug of GS-441524, it inhibits ‌RNA-dependent RNA polymerase (RdRp)‌, effectively blocking viral replication by incorporating into viral RNA chains. Primarily used to treat ‌COVID-19‌, it also demonstrates activity against ‌Ebola‌, ‌MERS-CoV‌, and ‌SARS-CoV‌. Supplied as a white crystalline powder with ≥99% purity (HPLC verified), it is stable under recommended storage conditions (‌-20°C‌).

‌Google Keywords‌: Remdesivir CAS 1809249-37-3, GS-5734 Supplier, COVID-19 Antiviral API, High-Purity RdRp Inhibitor

✅ ‌Key Advantages‌

       🔹 ‌High Purity & Stability‌

• ‌≥99% purity‌ (HPLC/UV verified) | Long-term stability at ‌-20°C‌.
  🔹 ‌Potent Antiviral Activity‌

• ‌EC50 = 30 nM‌ against murine hepatitis virus (MHV) | ‌74 nM EC50‌ for SARS-CoV and MERS-CoV in HAE cells.
  🔹 ‌Global Compliance‌

• Produced in ‌GMP-certified facilities‌ | Complies with ‌EP/USP/CP‌ standards.

🏥 ‌Application Fields‌

• ‌COVID-19 Treatment‌: Approved for emergency use in severe cases.

• ‌Ebola & MERS Research‌: Clinical trials for filovirus infections.

• ‌Antiviral Development‌: Key component in RNA virus therapeutic research.

📜 ‌Quality Certifications‌

• ‌Testing Methods‌: HPLC, NMR, MS, and microbial limit testing.

• ‌Certifications‌: ‌ISO 9001‌, ‌GMP‌, and ‌FDA-aligned protocols‌.

📊 ‌Market Trends‌

The ‌global antiviral drug market‌ is projected to grow at ‌6.5% CAGR (2025-2030)‌, driven by persistent COVID-19 variants and emerging RNA virus threats. Remdesivir remains a frontline therapeutic, with Asia-Pacific regions leading production and R&D.